Global Genetic Engineering Drug Market Research Report 2023

Publication ID:

PB503233176

Publication Date:

March 14, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Genetic Engineering Drug is also called Genetic Engineering or Genetic manipulation, and is the direct manipulation of an organism's genes using the Drug required in biotechnology.
Highlights
The global Genetic Engineering Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Genetic Engineering Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Genetic Engineering Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Genetic Engineering Drug include Shanghai Lansheng Guojian Pharmaceutical, Biotech Pharmaceutical, Anhui Anke Biotechnology, GeneScience Pharmaceuticals, Beijing SL Pharmaceutical, Jiangsu Sihuan Bioengineering, Shenzhen Neptunus Interlong Bio-Technique, 3SBio and Tonghua Dongbao Pharmaceutical, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genetic Engineering Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Engineering Drug.
The Genetic Engineering Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genetic Engineering Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Engineering Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Shanghai Lansheng Guojian Pharmaceutical
Biotech Pharmaceutical
Anhui Anke Biotechnology
GeneScience Pharmaceuticals
Beijing SL Pharmaceutical
Jiangsu Sihuan Bioengineering
Shenzhen Neptunus Interlong Bio-Technique
3SBio
Tonghua Dongbao Pharmaceutical
Segment by Type
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin
Segment by Application
Medicine
Research
Industrial
Agriculture
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genetic Engineering Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genetic Engineering Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Genetic Engineering Drug Market Overview
1.1 Product Overview and Scope of Genetic Engineering Drug
1.2 Genetic Engineering Drug Segment by Type
1.2.1 Global Genetic Engineering Drug Market Value Comparison by Type (2023-2029)
1.2.2 Monoclonal Antibody
1.2.3 Recombinant Human Erythropoietin
1.2.4 Recombinant Human Interferon
1.2.5 Recombinant Human Growth Hormone
1.2.6 Recombinant Human Insulin
1.3 Genetic Engineering Drug Segment by Application
1.3.1 Global Genetic Engineering Drug Market Value by Application: (2023-2029)
1.3.2 Medicine
1.3.3 Research
1.3.4 Industrial
1.3.5 Agriculture
1.3.6 Other
1.4 Global Genetic Engineering Drug Market Size Estimates and Forecasts
1.4.1 Global Genetic Engineering Drug Revenue 2018-2029
1.4.2 Global Genetic Engineering Drug Sales 2018-2029
1.4.3 Global Genetic Engineering Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Genetic Engineering Drug Market Competition by Manufacturers
2.1 Global Genetic Engineering Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Genetic Engineering Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Genetic Engineering Drug Average Price by Manufacturers (2018-2023)
2.4 Global Genetic Engineering Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Genetic Engineering Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genetic Engineering Drug, Product Type & Application
2.7 Genetic Engineering Drug Market Competitive Situation and Trends
2.7.1 Genetic Engineering Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genetic Engineering Drug Players Market Share by Revenue
2.7.3 Global Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genetic Engineering Drug Retrospective Market Scenario by Region
3.1 Global Genetic Engineering Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Genetic Engineering Drug Global Genetic Engineering Drug Sales by Region: 2018-2029
3.2.1 Global Genetic Engineering Drug Sales by Region: 2018-2023
3.2.2 Global Genetic Engineering Drug Sales by Region: 2024-2029
3.3 Global Genetic Engineering Drug Global Genetic Engineering Drug Revenue by Region: 2018-2029
3.3.1 Global Genetic Engineering Drug Revenue by Region: 2018-2023
3.3.2 Global Genetic Engineering Drug Revenue by Region: 2024-2029
3.4 North America Genetic Engineering Drug Market Facts & Figures by Country
3.4.1 North America Genetic Engineering Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Genetic Engineering Drug Sales by Country (2018-2029)
3.4.3 North America Genetic Engineering Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Genetic Engineering Drug Market Facts & Figures by Country
3.5.1 Europe Genetic Engineering Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Genetic Engineering Drug Sales by Country (2018-2029)
3.5.3 Europe Genetic Engineering Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genetic Engineering Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Genetic Engineering Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Genetic Engineering Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Genetic Engineering Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Genetic Engineering Drug Market Facts & Figures by Country
3.7.1 Latin America Genetic Engineering Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Genetic Engineering Drug Sales by Country (2018-2029)
3.7.3 Latin America Genetic Engineering Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genetic Engineering Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Genetic Engineering Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Genetic Engineering Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Genetic Engineering Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Genetic Engineering Drug Sales by Type (2018-2029)
4.1.1 Global Genetic Engineering Drug Sales by Type (2018-2023)
4.1.2 Global Genetic Engineering Drug Sales by Type (2024-2029)
4.1.3 Global Genetic Engineering Drug Sales Market Share by Type (2018-2029)
4.2 Global Genetic Engineering Drug Revenue by Type (2018-2029)
4.2.1 Global Genetic Engineering Drug Revenue by Type (2018-2023)
4.2.2 Global Genetic Engineering Drug Revenue by Type (2024-2029)
4.2.3 Global Genetic Engineering Drug Revenue Market Share by Type (2018-2029)
4.3 Global Genetic Engineering Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Genetic Engineering Drug Sales by Application (2018-2029)
5.1.1 Global Genetic Engineering Drug Sales by Application (2018-2023)
5.1.2 Global Genetic Engineering Drug Sales by Application (2024-2029)
5.1.3 Global Genetic Engineering Drug Sales Market Share by Application (2018-2029)
5.2 Global Genetic Engineering Drug Revenue by Application (2018-2029)
5.2.1 Global Genetic Engineering Drug Revenue by Application (2018-2023)
5.2.2 Global Genetic Engineering Drug Revenue by Application (2024-2029)
5.2.3 Global Genetic Engineering Drug Revenue Market Share by Application (2018-2029)
5.3 Global Genetic Engineering Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Shanghai Lansheng Guojian Pharmaceutical
6.1.1 Shanghai Lansheng Guojian Pharmaceutical Corporation Information
6.1.2 Shanghai Lansheng Guojian Pharmaceutical Description and Business Overview
6.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Portfolio
6.1.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments/Updates
6.2 Biotech Pharmaceutical
6.2.1 Biotech Pharmaceutical Corporation Information
6.2.2 Biotech Pharmaceutical Description and Business Overview
6.2.3 Biotech Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Biotech Pharmaceutical Genetic Engineering Drug Product Portfolio
6.2.5 Biotech Pharmaceutical Recent Developments/Updates
6.3 Anhui Anke Biotechnology
6.3.1 Anhui Anke Biotechnology Corporation Information
6.3.2 Anhui Anke Biotechnology Description and Business Overview
6.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Anhui Anke Biotechnology Genetic Engineering Drug Product Portfolio
6.3.5 Anhui Anke Biotechnology Recent Developments/Updates
6.4 GeneScience Pharmaceuticals
6.4.1 GeneScience Pharmaceuticals Corporation Information
6.4.2 GeneScience Pharmaceuticals Description and Business Overview
6.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GeneScience Pharmaceuticals Genetic Engineering Drug Product Portfolio
6.4.5 GeneScience Pharmaceuticals Recent Developments/Updates
6.5 Beijing SL Pharmaceutical
6.5.1 Beijing SL Pharmaceutical Corporation Information
6.5.2 Beijing SL Pharmaceutical Description and Business Overview
6.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Beijing SL Pharmaceutical Genetic Engineering Drug Product Portfolio
6.5.5 Beijing SL Pharmaceutical Recent Developments/Updates
6.6 Jiangsu Sihuan Bioengineering
6.6.1 Jiangsu Sihuan Bioengineering Corporation Information
6.6.2 Jiangsu Sihuan Bioengineering Description and Business Overview
6.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Portfolio
6.6.5 Jiangsu Sihuan Bioengineering Recent Developments/Updates
6.7 Shenzhen Neptunus Interlong Bio-Technique
6.6.1 Shenzhen Neptunus Interlong Bio-Technique Corporation Information
6.6.2 Shenzhen Neptunus Interlong Bio-Technique Description and Business Overview
6.6.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Portfolio
6.7.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments/Updates
6.8 3SBio
6.8.1 3SBio Corporation Information
6.8.2 3SBio Description and Business Overview
6.8.3 3SBio Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 3SBio Genetic Engineering Drug Product Portfolio
6.8.5 3SBio Recent Developments/Updates
6.9 Tonghua Dongbao Pharmaceutical
6.9.1 Tonghua Dongbao Pharmaceutical Corporation Information
6.9.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Portfolio
6.9.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genetic Engineering Drug Industry Chain Analysis
7.2 Genetic Engineering Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genetic Engineering Drug Production Mode & Process
7.4 Genetic Engineering Drug Sales and Marketing
7.4.1 Genetic Engineering Drug Sales Channels
7.4.2 Genetic Engineering Drug Distributors
7.5 Genetic Engineering Drug Customers
8 Genetic Engineering Drug Market Dynamics
8.1 Genetic Engineering Drug Industry Trends
8.2 Genetic Engineering Drug Market Drivers
8.3 Genetic Engineering Drug Market Challenges
8.4 Genetic Engineering Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Shanghai Lansheng Guojian Pharmaceutical
Biotech Pharmaceutical
Anhui Anke Biotechnology
GeneScience Pharmaceuticals
Beijing SL Pharmaceutical
Jiangsu Sihuan Bioengineering
Shenzhen Neptunus Interlong Bio-Technique
3SBio
Tonghua Dongbao Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂